Clinical Research Trials – The Next Step.
Distinguishing between impairments of working memory and inhibitory control in cases of early dementia.
Quantitative sensory testing (QST) assessments can be valuable tools in analgesic research.
The use pupillometry assessments to demonstrate TRV130 could cross the blood-brain barrier and engage µ-opioid receptors.
The disengagement of visual attention in Alzheimer’s disease: a longitudinal eye-tracking study.
Ziarco Initiates Phase 2a Clinical Trial of ZPL-389 in Atopic Dermatitis.
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
Lancaster University has filed a patent application for the drug, and it will be progressing into clinical trials run by the north-west research company MAC Clinical Research.
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.
